News and Breakthroughs: Robert H. Lurie Comprehensive Cancer Center of Northwestern University : Feinberg School of Medicine
Source: https://www.cancer.northwestern.edu/news/index.html
Archived: 2026-04-23 17:23
News and Breakthroughs: Robert H. Lurie Comprehensive Cancer Center of Northwestern University : Feinberg School of Medicine
Skip to main content
News and Breakthroughs
Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the Lurie Cancer Center
news archive
.
Visit our gallery
to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.
Understanding Cancer’s Hidden Vulnerabilities
04.15.2026
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are treated.
New Drug Doubles One-Year Survival in Pancreatic Cancer Trial
04.14.2026
Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone.
Targeting Novel Long Non-Coding RNA May Improve Glioblastoma Treatment
04.13.2026
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside a genetic amplification found in more than half of glioblastoma tumors, according to a Northwestern Medicine study published in Nature Cell Biology.
Long Non-Coding RNA May be a Promising Therapeutic Target for Cancer
04.09.2026
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its potential as a therapeutic target, according to a recent study published in Nature Communications.
Overlooked Cells Linked to Poor Outcomes in Breast Cancer
04.07.2026
A little-studied group of cancer cells circulating in the bloodstream may play a bigger role in breast cancer progression than previously thought, according to new research published in Science Translational Medicine that sheds light on how the disease spreads and why some patients fare worse than others.
Transcription Factors Form Continuous ‘Circuit’ That Regulates T-cell Exhaustion
04.06.2026
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion and migration during viral infection, which may inform future therapeutic strategies for managing infections and cancer, according to a recent Northwestern Medicine study.
40 Years of Breast Cancer Research: Lynn Sage Breast Cancer Foundation Celebrates Triumphs since Founding
03.31.2026
For 40 years, the Lynn Sage Breast Cancer Foundation has been a philanthropic partner of Northwestern University Feinberg School of Medicine, supporting breast cancer research, physician training, and clinical collaboration at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Fructose Uptake in Immune Cells Promotes Glioblastoma Growth
03.24.2026
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor microenvironment metabolize fructose to suppress immune responses and promote tumor growth, according to a recent study published in the Proceedings of the National Academy of Sciences.
Carolyn Passaglia Appointed Associate Director for Administration at Lurie Cancer Center
03.13.2026
Carolyn Passaglia Appointed Associate Director for Administration at Lurie Cancer Center
Calcium Signaling Channels Regulate Neuroinflammation and Motivation
03.12.2026
Northwestern Medicine scientists have discovered how calcium signaling channels in the brain’s immune cells regulate neuroinflammation and promote the development of behaviors associated with affective mood disorders, according to a recent study published in Science Signaling.
CAR T-cell Therapy Improves Survival in Relapsed or Refractory Lymphoma
03.04.2026
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet.
Trashing Cancer’s ‘Undruggable’ Proteins
03.03.2026
Northwestern scientists have developed polymers capable of grabbing proteins and directing them to the cell’s waste-disposal machinery, potentially triggering cancer cell death.
Targeting STING Pathway Triggers Cytotoxic and Immune Responses Against Meningioma
02.19.2026
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Communications.
HPV Cancer Vaccine Slows Tumor Growth, Extends Survival in Preclinical Model
02.18.2026
Northwestern scientists have discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to drug formulations that supercharge the immune system’s ability to attack tumors.
Targeting Cellular Mechanisms May Improve Immune Response in Chronic Infections
02.13.2026
Northwestern Medicine scientists have identified cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve therapeutic strategies for controlling chronic infection, according to a recent study.
Combination Treatment May Slow Disease Progression in Advanced Sarcoma
02.10.2026
An oral combination treatment may prevent disease progression in patients with advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology.
AI Model May Improve RNA Sequencing Research
02.09.2026
Scientists in the laboratory of Rendong Yang, PhD, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more accurately than conventional approaches, as detailed in a recent study published in Nature Communications.
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma
01.29.2026
Northwestern Medicine scientists have developed a new non-invasive approach that could help better determine which patients with glioblastoma are responding favorably to chemotherapy treatment and inform future treatment plans, according to a recent study published in Nature Communications.
New Underlying Mechanisms May Support Proper Transcriptional Regulation and Improve Targeted Therapies
01.26.2026
Northwestern Medicine scientists have discovered new mechanisms underlying transcriptional initiation and elongation control that support proper gene expression, which may inform targeted therapeutic approaches for many diseases, according to a recent study published in Molecular Cell.
How Inflammation Fuels Blood Cancer Risk
01.21.2026
A Northwestern Medicine-led study published in The Journal of Clinical Investigation has uncovered why older individuals with specific genetic mutations face a heightened risk of developing serious blood cancers.
Investigating HIV’s Hidden Immune Evasion Strategy
01.12.2026
A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering the sugars on their surface, hindering the host immune system and avoiding detection.
Lurie Cancer Center Announces New Leadership Appointments
01.09.2026
Lurie Cancer Center is proud to announce new leadership appointments following our recent NCI renewal.
Tanning Beds Triple Melanoma Risk, Potentially Causing Broad DNA Damage
01.07.2026
Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, according to a recent study.
Scientists Map the Human Genome in 4D
12.22.2025
In a landmark effort to understand how the physical structure of our DNA influences human biology, Northwestern investigators and the 4D Nucleome Project have unveiled the most detailed maps to date of the genome’s three‑dimensional organization across time and space, according to a new study published in Nature.
Faster Approach Determines Brain Cancer Treatment is Working
12.19.2025
Researchers at the Malnati Brain Tumor Institute – along with the University of Michigan – have developed a new and faster approach to determine if a treatment for the brain cancer glioblastoma is working.
Noninvasive Treatment Boosts Immune Response Against Glioblastoma
12.17.2025
Northwestern Medicine scientists, along with collaborators from the Washington University School of Medicine, have developed a noninvasive nanomedicine approach that may improve the treatment of glioblastoma, according to a recent study published in the Proceedings of the National Academy of Sciences.
Novel Biomarker May Predict Immunotherapy Resistance
12.11.2025
Northwestern Medicine scientists have identified a novel biomarker for immune immunotherapy resistance in cancer that may also serve as a potential therapeutic target for patients who don’t respond well to immunotherapy, according to a recent study published in The Journal of Clinical Investigation.
Exploring the Link Between RNA Modification and Prostate Cancer Growth
12.04.2025
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a well-known cancer-related protein and a major RNA modification process, which may inform new treatment strategies against prostate cancer.
Traveling with Stage 4 Cancer for the First Time
12.01.2025
Before cancer, I lived on flights and in hotel rooms and in the in-between spaces that only a certain kind of traveler understands.
See more news in the
article archive
.
Back to top
Skip to main content
News and Breakthroughs
Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the Lurie Cancer Center
news archive
.
Visit our gallery
to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.
Understanding Cancer’s Hidden Vulnerabilities
04.15.2026
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are treated.
New Drug Doubles One-Year Survival in Pancreatic Cancer Trial
04.14.2026
Patients who received an experimental drug developed at Northwestern University alongside standard chemotherapy were twice as likely to be alive after one year of treatment, compared to those receiving chemotherapy alone.
Targeting Novel Long Non-Coding RNA May Improve Glioblastoma Treatment
04.13.2026
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside a genetic amplification found in more than half of glioblastoma tumors, according to a Northwestern Medicine study published in Nature Cell Biology.
Long Non-Coding RNA May be a Promising Therapeutic Target for Cancer
04.09.2026
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its potential as a therapeutic target, according to a recent study published in Nature Communications.
Overlooked Cells Linked to Poor Outcomes in Breast Cancer
04.07.2026
A little-studied group of cancer cells circulating in the bloodstream may play a bigger role in breast cancer progression than previously thought, according to new research published in Science Translational Medicine that sheds light on how the disease spreads and why some patients fare worse than others.
Transcription Factors Form Continuous ‘Circuit’ That Regulates T-cell Exhaustion
04.06.2026
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion and migration during viral infection, which may inform future therapeutic strategies for managing infections and cancer, according to a recent Northwestern Medicine study.
40 Years of Breast Cancer Research: Lynn Sage Breast Cancer Foundation Celebrates Triumphs since Founding
03.31.2026
For 40 years, the Lynn Sage Breast Cancer Foundation has been a philanthropic partner of Northwestern University Feinberg School of Medicine, supporting breast cancer research, physician training, and clinical collaboration at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Fructose Uptake in Immune Cells Promotes Glioblastoma Growth
03.24.2026
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor microenvironment metabolize fructose to suppress immune responses and promote tumor growth, according to a recent study published in the Proceedings of the National Academy of Sciences.
Carolyn Passaglia Appointed Associate Director for Administration at Lurie Cancer Center
03.13.2026
Carolyn Passaglia Appointed Associate Director for Administration at Lurie Cancer Center
Calcium Signaling Channels Regulate Neuroinflammation and Motivation
03.12.2026
Northwestern Medicine scientists have discovered how calcium signaling channels in the brain’s immune cells regulate neuroinflammation and promote the development of behaviors associated with affective mood disorders, according to a recent study published in Science Signaling.
CAR T-cell Therapy Improves Survival in Relapsed or Refractory Lymphoma
03.04.2026
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet.
Trashing Cancer’s ‘Undruggable’ Proteins
03.03.2026
Northwestern scientists have developed polymers capable of grabbing proteins and directing them to the cell’s waste-disposal machinery, potentially triggering cancer cell death.
Targeting STING Pathway Triggers Cytotoxic and Immune Responses Against Meningioma
02.19.2026
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Communications.
HPV Cancer Vaccine Slows Tumor Growth, Extends Survival in Preclinical Model
02.18.2026
Northwestern scientists have discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to drug formulations that supercharge the immune system’s ability to attack tumors.
Targeting Cellular Mechanisms May Improve Immune Response in Chronic Infections
02.13.2026
Northwestern Medicine scientists have identified cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve therapeutic strategies for controlling chronic infection, according to a recent study.
Combination Treatment May Slow Disease Progression in Advanced Sarcoma
02.10.2026
An oral combination treatment may prevent disease progression in patients with advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology.
AI Model May Improve RNA Sequencing Research
02.09.2026
Scientists in the laboratory of Rendong Yang, PhD, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more accurately than conventional approaches, as detailed in a recent study published in Nature Communications.
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma
01.29.2026
Northwestern Medicine scientists have developed a new non-invasive approach that could help better determine which patients with glioblastoma are responding favorably to chemotherapy treatment and inform future treatment plans, according to a recent study published in Nature Communications.
New Underlying Mechanisms May Support Proper Transcriptional Regulation and Improve Targeted Therapies
01.26.2026
Northwestern Medicine scientists have discovered new mechanisms underlying transcriptional initiation and elongation control that support proper gene expression, which may inform targeted therapeutic approaches for many diseases, according to a recent study published in Molecular Cell.
How Inflammation Fuels Blood Cancer Risk
01.21.2026
A Northwestern Medicine-led study published in The Journal of Clinical Investigation has uncovered why older individuals with specific genetic mutations face a heightened risk of developing serious blood cancers.
Investigating HIV’s Hidden Immune Evasion Strategy
01.12.2026
A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering the sugars on their surface, hindering the host immune system and avoiding detection.
Lurie Cancer Center Announces New Leadership Appointments
01.09.2026
Lurie Cancer Center is proud to announce new leadership appointments following our recent NCI renewal.
Tanning Beds Triple Melanoma Risk, Potentially Causing Broad DNA Damage
01.07.2026
Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, according to a recent study.
Scientists Map the Human Genome in 4D
12.22.2025
In a landmark effort to understand how the physical structure of our DNA influences human biology, Northwestern investigators and the 4D Nucleome Project have unveiled the most detailed maps to date of the genome’s three‑dimensional organization across time and space, according to a new study published in Nature.
Faster Approach Determines Brain Cancer Treatment is Working
12.19.2025
Researchers at the Malnati Brain Tumor Institute – along with the University of Michigan – have developed a new and faster approach to determine if a treatment for the brain cancer glioblastoma is working.
Noninvasive Treatment Boosts Immune Response Against Glioblastoma
12.17.2025
Northwestern Medicine scientists, along with collaborators from the Washington University School of Medicine, have developed a noninvasive nanomedicine approach that may improve the treatment of glioblastoma, according to a recent study published in the Proceedings of the National Academy of Sciences.
Novel Biomarker May Predict Immunotherapy Resistance
12.11.2025
Northwestern Medicine scientists have identified a novel biomarker for immune immunotherapy resistance in cancer that may also serve as a potential therapeutic target for patients who don’t respond well to immunotherapy, according to a recent study published in The Journal of Clinical Investigation.
Exploring the Link Between RNA Modification and Prostate Cancer Growth
12.04.2025
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a well-known cancer-related protein and a major RNA modification process, which may inform new treatment strategies against prostate cancer.
Traveling with Stage 4 Cancer for the First Time
12.01.2025
Before cancer, I lived on flights and in hotel rooms and in the in-between spaces that only a certain kind of traveler understands.
See more news in the
article archive
.
Back to top